1 week Biogen receives breakthrough therapy designation for felzartamab, shares edge upInvesting.com
Biogen receives breakthrough therapy designation for felzartamab, shares edge up.
XBiogen receives breakthrough therapy designation for felzartamab, shares edge up.
X